Evidence map›Paper›PMID 41011494›Full record

ArticleMicroorganisms2025

Characterization of Drug Resistance Mutations in

Said Laatri, Safaa El Kassimi, El Mehdi Bentaleb, My Driss El Messaoudi, Joy Irobi, Bouchra Belkadi, Abdelkarim Filali-Maltouf, Hassan Ait Benhassou

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. A Comprehensive Review of Genetic Mechanisms ofInfection and drug resistance · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Said LaatriLaboratory of Microbiology and Molecular Biology, Faculty of Sciences of Rabat, Mohammed V University, Rabat 10100, Morocco.ORCID 0009-0006-9967-425X
Safaa El KassimiLaboratory of Microbiology and Molecular Biology, Faculty of Sciences of Rabat, Mohammed V University, Rabat 10100, Morocco.
El Mehdi BentalebPrevention & Therapeutics Center, Moroccan Foundation for Advanced Science, Innovation and Research (MAScIR), Rabat 10100, Morocco.
My Driss El MessaoudiLaboratory of Tuberculosis, Pasteur Institute of Morocco, Casablanca 20360, Morocco.
Joy IrobiBiomedical Research Institute, Hasselt University, 3500 Hasselt, Belgium.
Bouchra BelkadiLaboratory of Microbiology and Molecular Biology, Faculty of Sciences of Rabat, Mohammed V University, Rabat 10100, Morocco.ORCID 0000-0002-1709-3042
Abdelkarim Filali-MaltoufLaboratory of Microbiology and Molecular Biology, Faculty of Sciences of Rabat, Mohammed V University, Rabat 10100, Morocco.ORCID 0000-0002-2727-3389
Hassan Ait BenhassouPrevention & Therapeutics Center, Moroccan Foundation for Advanced Science, Innovation and Research (MAScIR), Mohammed VI Polytechnic University (UM6P), Ben Guerir 43150, Morocco.ORCID 0000-0002-5815-3531

Funding

VLIRUOS MA2020SIN288A104
6 · The paper itself

Abstract

Tuberculosis (TB) is a major public health concern worldwide and in Morocco, particularly considering the increasing burden of drug-resistant

Indexed as

extensively drug-resistant (XDR)multidrug-resistant (MDR)mycobacterium tuberculosistargeted sequencingtuberculosis

Identifiers

PMID41011494
PMCPMC12472841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.